Back to Search
Start Over
Barinthus lays off 25% of staff, sidelines prostate cancer program to stretch out cash.
Barinthus lays off 25% of staff, sidelines prostate cancer program to stretch out cash.
- Source :
- FierceBiotech; 6/13/2024, pN.PAG-N.PAG, 1p
- Publication Year :
- 2024
-
Abstract
- Barinthus used positive data from a pair of phase 2 trials for its hepatitis B therapy as justification for jettisoning a quarter of its workforce. [ABSTRACT FROM AUTHOR]
- Subjects :
- LAYOFFS
STRETCH (Physiology)
PROSTATE cancer
Subjects
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 177909711